| USD millions | FY2024 | FY2025 | TTM |
|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 |
| Cost of revenue | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 |
| Research & development | — | 0.0 | — |
| Selling, general & administrative | — | 1.1 | — |
| Selling & marketing | — | 0.0 | — |
| Operating expenses | 0.0 | 1.1 | 1.5 |
| Operating income | (0.0) | (1.1) | (1.5) |
| Interest expense | — | 0.0 | — |
| Interest income | 0.0 | 5.8 | — |
| Other income / expense | — | 5.8 | — |
| Pre-tax income | (0.0) | 4.7 | 8.3 |
| Income tax | 0.0 | 0.0 | 0.0 |
| Net income | (0.0) | 4.7 | 8.3 |
| Discontinued operations | — | 0.0 | — |
| Other net income adjustments | — | 0.0 | — |
| EPS, basic (per share) | (0.00) | 0.23 | 0.27 |
| EPS, diluted (per share) | (0.00) | 0.23 | 0.27 |
| EBITDA | (0.0) | (1.1) | (1.5) |
| Depreciation & amortization | — | 0.0 | — |
| Weighted average shares (shares) | 25,600,000 | 20,523,764 | — |
| Weighted average diluted shares (shares) | 25,600,000 | 20,523,764 | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
